Delivery Order SPE2DB22D2005-SPE2DB24FJQJ8

Award Date 7/22/24
Potential Completion Date 8/12/24
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a delivery order contract worth $134,929.44 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of VARIVAX vaccine with diluents. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the...
The U.S. Defense Logistics Agency (DLA) awarded a $14,339.55 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of VARIVAX vaccine with diluents. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and medical supplies to support military treatment...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The $77,771.83 contract is for the supply of VARIVAX vaccine with diluents, with a period of performance through October 18, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to...
The U.S. Defense Logistics Agency (DLA) awarded a $2,867.91 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide VARIVAX vaccine with diluents. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of pharmaceutical products and medical supplies for military treatment programs globally....
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,867.91 firm-fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide VARIVAX vaccine with diluents. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to...
The U.S. Defense Logistics Agency (DLA) has awarded a $2,811.03 firm fixed-price delivery order contract to AmerisourceBergen Drug Corporation for the supply of VARIVAX vaccine with diluents. This contract has an ultimate completion date of October 4, 2024. As a major pharmaceutical distributor, AmerisourceBergen leverages its extensive supply chain to provide a wide range of essential medical commodities, including prescription drugs, vaccines, and medical supplies, to support various federal...
The Defense Logistics Agency (DLA) has awarded a $19,119.60 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division for the supply of VARIVAX vaccine with diluents. This order falls under a larger indefinite delivery contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities...
The U.S. Defense Logistics Agency (DLA) awarded a $4,685.05 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of VARIVAX vaccine with diluents. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a large pharmaceutical distributor, to provide the VARIVAX vaccine with diluent. The award, valued at $28,679.10, has an ultimate completion date of May 2, 2024. AmerisourceBergen Drug Corp will deliver the vaccines and related medical supplies to support military treatment programs and facilities under this order, which is part of a larger indefinite delivery contract (IDC) with DLA...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,867.91 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical and medical supply distributor, to provide VARIVAX vaccine with diluents. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB24FJQJ8
    Delivery Order

The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a $2,811.03 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of VARIVAX vaccine with diluents. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is expected to be completed by August 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, leverages its extensive supply chain to deliver essential pharmaceutical and medical products to various federal agencies and healthcare providers.

Generated 10/21/24, 9:30 AM